The CEO of a stem cell platform company needed to create a briefing package of its offering for investors in its next financing round.
MSC was engaged to position the company’s communication strategy, conduct market research to build the business case and to package the information in a comprehensive prospectus. To position the company against other allogeneic and autologous competitors, an envisioned TPP was developed and insights were gathered to build an attractive investment case. Through benchmark studies and client workshops, the foundation was laid out for a credible development and commercial strategy. The project outcome was subsequently used to pitch for private investors and the client is now preparing for a potential initial public offering.